Onconetix Stock Dips Amid Merger Agreement with Ocuvex

Onconetix shares are trading lower after entering a definitive merger agreement with Ocuvex, which will result in Ocuvex shareholders receiving 90% of the combined company, raising concerns among Onconetix investors about dilution and future control.